Olink Holding AB (publ) (OLK): Price and Financial Metrics


Olink Holding AB (publ) (OLK): $11.28

0.02 (+0.18%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

OLK POWR Grades


  • OLK scores best on the Growth dimension, with a Growth rank ahead of 81.38% of US stocks.
  • The strongest trend for OLK is in Momentum, which has been heading down over the past 179 days.
  • OLK ranks lowest in Quality; there it ranks in the 13th percentile.

OLK Stock Summary

  • OLK's went public 1.01 years ago, making it older than merely 0.24% of listed US stocks we're tracking.
  • With a price/sales ratio of 23.49, Olink Holding AB (publ) has a higher such ratio than 93.61% of stocks in our set.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.12 for Olink Holding AB (publ); that's greater than it is for only 9.19% of US stocks.
  • Stocks that are quantitatively similar to OLK, based on their financial statements, market capitalization, and price volatility, are BELFA, OSTK, NYT, MOG.A, and TCCO.
  • OLK's SEC filings can be seen here. And to visit Olink Holding AB (publ)'s official web site, go to www.olink.com.

OLK Valuation Summary

  • In comparison to the median Healthcare stock, OLK's price/earnings ratio is 1639.45% lower, now standing at -561.9.
  • Over the past 159 days, OLK's price/sales ratio has gone down 8.7.
  • OLK's EV/EBIT ratio has moved down 8070.6 over the prior 159 days.

Below are key valuation metrics over time for OLK.

Stock Date P/S P/B P/E EV/EBIT
OLK 2021-08-31 70.5 7.4 -561.9 43009.4
OLK 2021-08-30 70.4 7.4 -561.3 42967.1
OLK 2021-08-27 69.8 7.3 -556.2 42561.2
OLK 2021-08-26 69.0 7.2 -550.6 42114.1
OLK 2021-08-25 70.6 7.4 -563.3 43121.2
OLK 2021-08-24 68.8 7.2 -549.0 41987.1

OLK Stock Price Chart Interactive Chart >

Price chart for OLK

OLK Price/Volume Stats

Current price $11.28 52-week high $38.78
Prev. close $11.26 52-week low $9.21
Day low $11.25 Volume 38,189
Day high $11.32 Avg. volume 279,955
50-day MA $14.70 Dividend yield N/A
200-day MA $20.67 Market Cap 1.34B

Olink Holding AB (publ) (OLK) Company Bio


Olink Holding AB (publ) provides various products and services for academic, government, biopharmaceutical, biotechnology, and other institutions focused on life science research. Its products include Olink Explore for cardiovascular and metabolic diseases, oncology, neurology, or inflammation; Olink Target product line; and Olink Focus product line consists of custom developed solutions for customers that have identified a small number of proteins of interest to focus on.


OLK Latest News Stream


Event/Time News Detail
Loading, please wait...

OLK Latest Social Stream


Loading social stream, please wait...

View Full OLK Social Stream

Latest OLK News From Around the Web

Below are the latest news stories about Olink Holding AB (publ) that investors may wish to consider to help them evaluate OLK as an investment opportunity.

Leerink Partners Remains a Buy on Olink Holding (OLK)

Leerink Partners analyst Puneet Souda reiterated a Buy rating on Olink Holding (OLK – Research Report) yesterday and set a price target of $25.00. The company's shares closed last Tuesday at $18.60. According to TipRanks.com, Souda is ranked 0 out of 5 stars with an average return of -3.5% and a 36.7% success rate. Souda covers the Healthcare sector, focusing on stocks such as AbCellera Biologics, Castle Biosciences, and Twist Bioscience. Currently, the analyst consensus on Olink Holding is a Moderate Buy with an average price target of $25.00.

Catie Powers on TipRanks | February 15, 2022

8 Medical Stocks to Buy According to Mitchell Blutt’s Consonance Capital

In this article, we will be looking at the 8 medical stocks to buy according to Mitchell Blutt’s Consonance Capital. You can skip our detailed analysis of these stocks and head directly to 3 Medical Stocks to Buy According to Mitchell Blutt’s Consonance Capital. Mitchell Blutt is an American physician-businessman. He is one of the […]

Yahoo | February 15, 2022

Olink reports fourth quarter and full year 2021 financial results and provides outlook for 2022

Uppsala, Sweden, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2021, and provided revenue guidance for the full year 2022. Highlights Fourth quarter revenue totaled $43.7 million, representing year over year growth of 61% on a reported basis and 45% on a constant currency adjusted like-for-like basisFull year 2021 revenue totaled $95.0 million, achieving yea

Yahoo | February 14, 2022

Olink to present at February investor conferences

UPPSALA, Sweden, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Jon Heimer, CEO, and Oskar Hjelm, CFO, will participate in the following virtual investor conferences: BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceFireside chat on Tuesday, February 15th at 8:30 am ET 11th Annual SVB Leerink Global Healthcare ConferenceFireside chat on Friday, February 18th at 8:40 am ET BTIG hosted events are intended for prospecti

Yahoo | February 1, 2022

Nasdaq’s European Markets Delivered Record Year in 2021

- Solidified Nasdaq position as the leading European listings hub with 219 new equity listings, including a record number of 174 initial public offerings (IPOs), raising a total of EUR 13.4 billion- Retail inflow and large interest in SME trading spurred all-time high levels in equity and derivative trading- Continued to lead in ESG with venture investment in Puro.earth and new product launches STOCKHOLM, Sweden, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) announced today that Nasdaq

Yahoo | January 21, 2022

Read More 'OLK' Stories Here

OLK Price Returns

1-mo -22.26%
3-mo -36.05%
6-mo -49.53%
1-year -65.25%
3-year N/A
5-year N/A
YTD -38.02%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7825 seconds.